Soleno Therapeutics
SLNO
#4530
Rank
NZ$3.86 B
Marketcap
NZ$71.93
Share price
-3.40%
Change (1 day)
-7.04%
Change (1 year)

Market capitalization of Soleno Therapeutics (SLNO)

Market cap: NZ$3.86 Billion

As of January 2026 Soleno Therapeutics has a market cap of NZ$3.86 Billion. This makes Soleno Therapeutics the world's 4530th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Soleno Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.86 B-12.57%
2025NZ$4.41 B28.96%
2024NZ$3.42 B76.52%
2023NZ$1.94 B7528.64%
2022NZ$25.44 M-46.92%
2021NZ$47.93 M-77.49%
2020NZ$0.21 B9.24%
2019NZ$0.19 B140.82%
2018NZ$80.95 M219.34%
2017NZ$25.35 M35.61%
2016NZ$18.69 M-50.66%
2015NZ$37.89 M194.04%
2014NZ$12.88 M

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Soleno Therapeutics was reported to be:

NZ$3.86 Billion
by Nasdaq info icon info icon
NZ$3.86 Billion
by CompaniesMarketCap info icon info icon